Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ASCO buzz coming

<< Previous

Bullboard Posts

Next >>

Comment by Angler101on Apr 25, 2023 12:35pm

96 Views

Post# 35412643

RE:RE:RE:ASCO buzz coming

If management is saying they can and will do something about the share price, I could see accelerated approval before ASCO being the perfect catalyst to make that happen....and what a slam-dunk that would be for a big pharma buyout!...woohooo!

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season